Participant Perspectives and Experiences Entering an Intensively Monitored Antiretroviral Pause: Results from the AIDS Clinical Trials Group A5345 Biomarker Study

Author:

Diepstra Karen L.1,Barr Liz2,Palm David3,Hogg Evelyn4,Mollan Katie R.5,Henley Laney1,Stover Angela M.1,Simoni Jane M.67,Sugarman Jeremy8,Brown Brandon9,Sauceda John A.10,Deeks Steven11,Fox Lawrence12,Gandhi Rajesh T.13,Smith Davey14,Li Jonathan Z.15,Dubé Karine1

Affiliation:

1. UNC Gillings School of Global Public Health, Chapel Hill, North Carolina, USA.

2. AIDS Clinical Trials Group (ACTG) Community Scientific Sub-Committee, Baltimore, Maryland, USA.

3. Institute of Global Health and Infectious Diseases (IGHID), University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

4. Social & Scientific Systems, a DLH Company, Silver Spring, Maryland, USA.

5. Center for AIDS Research (CFAR), School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

6. Department of Psychology, University of Washington, Seattle, Washington, USA.

7. Department of Global Health and Gender, Women, and Sexuality Studies, University of Washington, Seattle, Washington, USA.

8. Johns Hopkins Berman Institute for Bioethics, Baltimore, Maryland, USA.

9. Department of Social Medicine, Population and Public Health, Center for Healthy Communities, University of California, Riverside School of Medicine, Riverside, California, USA.

10. Division of Prevention Sciences, Center for AIDS Prevention Studies (CAPS), University of California, San Francisco, San Francisco, California, USA.

11. Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco, San Francisco, California, USA.

12. National Institute of Health (NIH) Division of AIDS (DAIDS), Bethesda, Maryland, USA.

13. Massachusetts General Hospital, Boston, Massachusetts, USA.

14. Division of Infectious Diseases and Global Health, University of California, San Diego, California, USA.

15. Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3